These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 31083197)

  • 81. Circulating microRNA biomarkers for lung cancer detection in Western populations.
    Yu H; Guan Z; Cuk K; Brenner H; Zhang Y
    Cancer Med; 2018 Oct; 7(10):4849-4862. PubMed ID: 30259714
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries.
    Bray F; Ferlay J; Soerjomataram I; Siegel RL; Torre LA; Jemal A
    CA Cancer J Clin; 2018 Nov; 68(6):394-424. PubMed ID: 30207593
    [TBL] [Abstract][Full Text] [Related]  

  • 83. P16
    Tuo L; Sha S; Huayu Z; Du K
    Thorac Cancer; 2018 Aug; 9(8):1032-1040. PubMed ID: 29927090
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Serum and blood based biomarkers for lung cancer screening: a systematic review.
    Chu GCW; Lazare K; Sullivan F
    BMC Cancer; 2018 Feb; 18(1):181. PubMed ID: 29439651
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Preferred Reporting Items for a Systematic Review and Meta-analysis of Diagnostic Test Accuracy Studies: The PRISMA-DTA Statement.
    McInnes MDF; Moher D; Thombs BD; McGrath TA; Bossuyt PM; ; Clifford T; Cohen JF; Deeks JJ; Gatsonis C; Hooft L; Hunt HA; Hyde CJ; Korevaar DA; Leeflang MMG; Macaskill P; Reitsma JB; Rodin R; Rutjes AWS; Salameh JP; Stevens A; Takwoingi Y; Tonelli M; Weeks L; Whiting P; Willis BH
    JAMA; 2018 Jan; 319(4):388-396. PubMed ID: 29362800
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Comparing the diagnostic accuracy of five common tumour biomarkers and CA19-9 for pancreatic cancer: a protocol for a network meta-analysis of diagnostic test accuracy.
    Ge L; Pan B; Song F; Ma J; Zeraatkar D; Zhou J; Tian J
    BMJ Open; 2017 Dec; 7(12):e018175. PubMed ID: 29282264
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Association between prospective registration and overall reporting and methodological quality of systematic reviews: a meta-epidemiological study.
    Ge L; Tian JH; Li YN; Pan JX; Li G; Wei D; Xing X; Pan B; Chen YL; Song FJ; Yang KH
    J Clin Epidemiol; 2018 Jan; 93():45-55. PubMed ID: 29111471
    [TBL] [Abstract][Full Text] [Related]  

  • 88. AMSTAR 2: a critical appraisal tool for systematic reviews that include randomised or non-randomised studies of healthcare interventions, or both.
    Shea BJ; Reeves BC; Wells G; Thuku M; Hamel C; Moran J; Moher D; Tugwell P; Welch V; Kristjansson E; Henry DA
    BMJ; 2017 Sep; 358():j4008. PubMed ID: 28935701
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Evaluation of Tumor-Derived Exosomal miRNA as Potential Diagnostic Biomarkers for Early-Stage Non-Small Cell Lung Cancer Using Next-Generation Sequencing.
    Jin X; Chen Y; Chen H; Fei S; Chen D; Cai X; Liu L; Lin B; Su H; Zhao L; Su M; Pan H; Shen L; Xie D; Xie C
    Clin Cancer Res; 2017 Sep; 23(17):5311-5319. PubMed ID: 28606918
    [No Abstract]   [Full Text] [Related]  

  • 90. Lung Cancer Screening.
    Hoffman RM; Sanchez R
    Med Clin North Am; 2017 Jul; 101(4):769-785. PubMed ID: 28577626
    [TBL] [Abstract][Full Text] [Related]  

  • 91. The methodological and reporting quality of systematic reviews from China and the USA are similar.
    Tian J; Zhang J; Ge L; Yang K; Song F
    J Clin Epidemiol; 2017 May; 85():50-58. PubMed ID: 28063911
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Circulating tumor cells as a potential biomarker in diagnosis of lung cancer: a systematic review and meta-analysis.
    Huang H; Shi Y; Huang J; Wang X; Zhang R; Chen H
    Clin Respir J; 2018 Feb; 12(2):639-645. PubMed ID: 27778482
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Lung Cancer Staging and Prognosis.
    Woodard GA; Jones KD; Jablons DM
    Cancer Treat Res; 2016; 170():47-75. PubMed ID: 27535389
    [TBL] [Abstract][Full Text] [Related]  

  • 94. The quality of evidence in Chinese meta-analyses needs to be improved.
    Yao L; Sun R; Chen YL; Wang Q; Wei D; Wang X; Yang K
    J Clin Epidemiol; 2016 Jun; 74():73-9. PubMed ID: 26780259
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Is chest X-ray screening for lung cancer in smokers cost-effective? Evidence from a population-based study in Italy.
    Pertile P; Poli A; Dominioni L; Rotolo N; Nardecchia E; Castiglioni M; Paolucci M; Mantovani W; Imperatori A
    Cost Eff Resour Alloc; 2015; 13():15. PubMed ID: 26366122
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Can EGFR mutations in plasma or serum be predictive markers of non-small-cell lung cancer? A meta-analysis.
    Wu Y; Liu H; Shi X; Song Y
    Lung Cancer; 2015 Jun; 88(3):246-53. PubMed ID: 25837799
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Potential biomarkers for lung cancer screening.
    Sozzi G; Boeri M
    Transl Lung Cancer Res; 2014 Jun; 3(3):139-48. PubMed ID: 25806293
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Screening and early detection efforts in lung cancer.
    Kanodra NM; Silvestri GA; Tanner NT
    Cancer; 2015 May; 121(9):1347-56. PubMed ID: 25641734
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015: elaboration and explanation.
    Shamseer L; Moher D; Clarke M; Ghersi D; Liberati A; Petticrew M; Shekelle P; Stewart LA;
    BMJ; 2015 Jan; 350():g7647. PubMed ID: 25555855
    [TBL] [Abstract][Full Text] [Related]  

  • 100. The reporting characteristics and methodological quality of Cochrane reviews about health policy research.
    Xiu-xia L; Ya Z; Yao-long C; Ke-hu Y; Zong-jiu Z
    Health Policy; 2015 Apr; 119(4):503-10. PubMed ID: 25260911
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.